Torticollis: Clinical Trials

119 trials for Torticollis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 11 recruiting, 10 unknown, 8 terminated. 28 Not applicable, 19 Phase 2, 13 Phase 3, 12 Phase 4, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 9, Recruiting 7, Unknown 4, Terminated 3, Enrolling by invitation 2, Not yet recruiting 2, Withdrawn 1
Phase 219Completed 10, Recruiting 4, Unknown 3, Terminated 2
Phase 313Completed 13
Phase 412Completed 10, Terminated 1, Unknown 1
Phase 18Completed 5, Unknown 2, Withdrawn 1
Early Phase 11Completed 1

Follow Torticollis: new trials by email Literature Review of Torticollis trials Research Report on Torticollis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Cervical Range of Motion Restrictions in Infants With Arthrogenic Torticollis - A Feasibility Study
Mobilisation of the upper cervical spine (but the effectiveness of the investigation is not part of the study evaluation) - Torticollis (Arthrogenic)
Not yet recruitingBalgrist University Hospital102026-10-072026-10-08
Noninvasive Brain Stimulation for Cervical Dystonia
Active continuous theta-burst stimulation, Sham continuous theta-burst stimulation - Cervical Dystonia
Not applicableRecruitingFondazione Policlinico Universitario Campus Bio-Medico262026-07-062026-09-17
Zinc as an Adjunctive Therapy for Cervical Dystonia
Zinc citrate, Placebo - Cervical Dystonia
Phase 2RecruitingUniversity of Florida252026-06-012026-05-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
VIM0423, VIM0423 Placebo - Dystonia
Phase 2RecruitingVima Therapeutics1002026-02-052026-10-26
UltraSound-Guided Versus Non-Ultrasound-Guided Botulinum Toxin Injections in Cervical Dystonia [CUSTODY]
Ultrasound-guided botulinum toxin injection, Non-ultrasound-guided botulinum toxin injection - Idiopathic Cervical Dystonia
Not applicableRecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1002025-11-012026-02-13
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Corabotase, Placebo - Cervical Dystonia
Phase 2RecruitingIpsen1322025-06-302026-09-08
An Observational Study of Individuals With Isolated Dystonia
Isolated/Primary Dystonia That Affects More Than One Region of the Body
Active not recruitingVima Therapeutics2002025-06-172026-09-21
Using Technology for Prediction and Prevention of Infant Torticollis and Plagiocephaly
in-app notification - Torticollis
Not applicableNot yet recruitingCollege of Staten Island, the City University of New York562025-06-012024-06-26
Development in Children Diagnosed With Congenital Muscular Torticollis
Torticollis Congenital, Motor Development
CompletedGazi University402025-03-132025-06-25
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
cervical vibrotactile stimulation - Cervical Dystonia
Not applicableRecruitingUniversity of Minnesota502025-03-102026-10-01
Study of the Oral Treatment MTR-601 in Cervical Dystonia
MTR-601, Placebo - Cervical Dystonia
Phase 2TerminatedMotric Bio382025-02-282026-09-17
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
Valbenazine, Placebo - Cervical Dystonia
Phase 2RecruitingVirginia Commonwealth University202024-12-172026-06-04
Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia
LIFUS - GPi Active, LIFUS - DN Active, LIFUS - Sham - Cervical Dystonia
Not applicableRecruitingRobert Chen482024-11-182026-07-08
Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia
Cervical Dystonia
TerminatedFondation Ophtalmologique Adolphe de Rothschild212024-09-102025-12-17
Relationship Between Home Environment and Development in Children Diagnosed With Muscular Torticollis
Affordances in the Home Environment for Motor Development-Infant Scale, Peabody Developmental Motor Scales-2, Test Of Sensory Functions In Infants (TSFI) - Congenital Muscular Torticollis, Motor Development
CompletedGazi University402023-12-102024-03-25
Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia
GPi-DBS, STN-DBS, GPi-DBS devices - Cervical Dystonia
Not applicableNot yet recruitingChinese PLA General Hospital982023-09-012023-07-21
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
CC BoNT/A, CF BoNT/A, CF to CC BoNT/A - Cervical Dystonia
CompletedMerz Therapeutics GmbH2702023-07-082024-08-21
Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation
Repositioning Therapy, Cranial Remolding Orthosis - Deformational Plagiocephaly, Deformational Posterior Plagiocephaly
Not applicableRecruitingUniversity of Texas Southwestern Medical Center652023-05-232026-08-31
Exercise Program for Patients With Cervical Dystonia Who Are Treated With Botulinum Toxin Type A
Stretching and Strengthening Exercises, Breathing and Rhythmic Coordination Exercises - Dystonia, Cervical
Not applicableRecruitingProf. Dr. Şehim Kutlay342022-10-012025-09-18
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
DystoniaNet-based diagnosis of isolated dystonia - Dystonia, Drug Induced Dystonia
Not applicableRecruitingMassachusetts Eye and Ear Infirmary10002022-06-012025-12-02

Showing 20 of 119. Sign in to see all of them.

Narrower conditions

Dystonia (18)  ·  Dystonic Disorders (11)  ·  Blepharospasm (10)  ·  Congenital torticollis (6)  ·  Movement Disorders (5)  ·  Muscle Spasticity (4)  ·  Cervical Dystonia, Primary (3)  ·  Essential Tremor (3)  ·  Hemifacial Spasm (3)  ·  Dyskinesias (2)  ·  Dystonia musculorum deformans type 1 (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Parkinson Disease (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (119)  ·  Signs and Symptoms (118)  ·  Dyskinesias (117)  ·  Neurologic Manifestations (117)  ·  Dystonia (101)  ·  Nervous System Diseases (26)  ·  Central Nervous System Diseases (15)  ·  Eye Diseases (10)  ·  Eyelid Diseases (10)  ·  Movement Disorders (10)  ·  Musculoskeletal Diseases (7)  ·  Muscular Diseases (5)  ·  Neuromuscular Manifestations (5)  ·  Brain Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)

Interventions

Botulinum Toxins, Type A (30)  ·  abobotulinumtoxinA (13)  ·  Botulinum Toxins (6)  ·  incobotulinumtoxinA (5)  ·  Deep Brain Stimulation (3)  ·  Injections (3)  ·  Transcranial Magnetic Stimulation (3)  ·  rimabotulinumtoxinB (3)  ·  Physical Therapy Modalities (2)  ·  prabotulinumtoxin A (2)  ·  valbenazine (2)  ·  Amlodipine (1)  ·  Dronabinol (1)  ·  Drug Delivery Systems (1)  ·  Electrodes (1)

Sponsors

Ipsen (11)  ·  Allergan (9)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (8)  ·  University of Florida (7)  ·  Fondation Ophtalmologique Adolphe de Rothschild (4)  ·  Eisai Co., Ltd. (3)  ·  Merz Pharmaceuticals GmbH (3)  ·  Revance Therapeutics, Inc. (3)  ·  University of Minnesota (3)  ·  University of Texas Southwestern Medical Center (3)  ·  Western University, Canada (3)  ·  AEON Biopharma, Inc. (2)  ·  Department of Medical Services Ministry of Public Health of Thailand (2)  ·  Gazi University (2)  ·  Medy-Tox (2)

Countries

United States (57)  ·  Canada (16)  ·  France (14)  ·  Germany (12)  ·  Austria (8)  ·  United Kingdom (8)  ·  Poland (7)  ·  Czechia (6)  ·  Italy (6)  ·  Russia (6)  ·  Turkey (Türkiye) (6)  ·  Australia (5)  ·  Thailand (5)  ·  Japan (4)  ·  China (3)

Top investigators

Akira Endo (2)  ·  Aparna Wagle Shukla, MD (2)  ·  Joseph Jankovic (2)  ·  Mandar Jog, MD (2)  ·  Alberto Espay, MD (1)  ·  Ann Marie S Pace, MPT (1)  ·  Aparna Wagle Shukla (1)  ·  Beom S Jeon, MD, PhD (1)  ·  Bin Liu, MD (1)  ·  Brian Berman (1)  ·  Carolyn Austin (1)  ·  Chu-Hsu Lin, MD (1)

Results publications

PMID 19191832, PMID 20359934, PMID 25324317, PMID 34316644, PMID 17905796, PMID 20801261, PMID 21764407, PMID 22021883, PMID 22054223, PMID 22398268, PMID 23604344, PMID 23687362, PMID 23779062, PMID 24951081, PMID 25127231, PMID 25168295, PMID 25175271, PMID 25476727, PMID 25524875, PMID 25595221, PMID 25823758, PMID 25923718, PMID 26074391, PMID 27383684, PMID 27624627, PMID 27653448, PMID 27774495, PMID 27903810, PMID 28138245, PMID 28192488, PMID 29326293, PMID 29530726, PMID 29731634, PMID 30009213, PMID 31350358, PMID 31614700, PMID 31892114, PMID 32102606, PMID 32884828, PMID 33524060, PMID 35330880, PMID 35847221, PMID 37832982, PMID 38295339, PMID 38386480, PMID 40439027, PMID 40986093, PMID 4842939, PMID 9474110

NIH funding

2005 (2), 2004 (1), KL2TR000065 (1), U54NS065701 (1)